Amphenol Corporation (A1PH34)
B3 Stock Exchange · Brazil · prices in BRL · close of 27 Oct 2026
Key indicators
| Last close | BRL 35.05 |
|---|---|
| 52-week range | 24.72 – 68.20 |
| Return, 1 month / 3 months | −3.5% / +9.9% |
| Return, 1 year / 3 years | +15.6% / +309.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 52 |
| Volatility (1 year) | 80.6% |
| Worst drawdown (1 year) | -44.4% |
| Average daily value traded | 0.89M BRL |
| Dividend yield | 19.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Amphenol Corporation makes electrical, electronic and fiber optic connectors, cable assemblies and interconnect systems. Its products connect and carry power and signals inside equipment used by customers in automotive, broadband, industrial, military, aerospace and mobile device markets. The company also supplies sensors and antenna products. Amphenol is based in Wallingford, Connecticut, in the United States, and serves equipment makers around the world through its connector and interconnect business.
Amphenol Corporation is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code A1PH34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Amphenol Corporation (A1PH34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 35.05 on 27 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 617 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 15.6% and over the last three months it rose 9.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.2% | ||
| From 52-week high | -36.7% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 9.9% | ||
| 6-month return | 14.8% | ||
| 12-month return, skipping the last month | 19.8% | ||
| Stability (higher is calmer) | 17 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 80.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -44.4% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 0.89M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 85 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 19.8% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +5.4% |
|---|---|
| 1 month | −3.5% |
| 3 months | +9.9% |
| 6 months | +14.8% |
| 1 year | +15.6% |
| 3 years | +309.2% |
| 5 years | +297.5% |
Signals
| 50-day / 200-day average | 35.20 / 32.39 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.59 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Sep 2026 | USD 0.0372 |
| 22 Jun 2026 | USD 0.4460 |
| 20 Mar 2026 | USD 0.4368 |
| 15 Dec 2025 | USD 0.4712 |
| 15 Sep 2025 | USD 0.3091 |
| 16 Jun 2025 | USD 0.3202 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.